Clinical-stage cancer biotech Nouscom raises $135M in Series D funding to advance its lead cancer vaccine through Phase 2 trials.
Amount Raised
$135 Million
Round Type
Series D
BaselBiotechnologyHealth CareTherapeuticsDescription
Nouscom, a clinical-stage cancer biotechnology company, has raised $135 million in an oversubscribed Series D funding round. The capital will be used to advance the company's lead cancer vaccine candidate through Phase 2 clinical trials. This funding demonstrates investor confidence in Nouscom's therapeutic approach to treating cancer.
Quick answer
Nouscom raised $135 Million in a Series D round, dated October 19, 2026. Nouscom is based in Basel, Basel City, Switzerland.
- How much did Nouscom raise?
- Nouscom raised $135 Million in a Series D round on October 19, 2026.
- What does Nouscom do?
- Nouscom is a private clinical stage immuno-oncology company developing off-the-shelf and personalized cancer immunotherapies using proprietary viral vectors with demonstrated high immunogenicity in patients.
- Where is Nouscom based and how big is it?
- Nouscom is based in Basel, Basel City, Switzerland. Fundz records about 11 employees.
- Who are the decision-makers at Nouscom?
- Fundz holds 1 contact at Nouscom. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Nouscom that raised within 45 days of this round, from Fundz verified event records.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- Neurosterix raised $105M (Series B) on November 11, 2026.
- VectorY raised $83M on November 11, 2026.
- Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
- SRTD biotech raised $35M (Seed) on November 9, 2026.
Who to call at Nouscom, and when
A new round usually means Nouscom is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nouscom raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nouscom, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nouscom. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nouscom raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nouscom raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.